Drug Abuse, Drug Treatment, and Public Policy

1996 ◽  
pp. 77-98 ◽  
Author(s):  
Sharon M. Hall ◽  
H. Westley Clark ◽  
Karen Lea Sees
2015 ◽  
Vol 48 (1) ◽  
pp. 1-7 ◽  
Author(s):  
R. Kathryn McHugh ◽  
Suzanne Nielsen ◽  
Roger D. Weiss

Author(s):  
David J. Nutt ◽  
Fergus D. Law

Drug abuse, misuse, and addiction are major issues in society because of their enormous personal, social, and economic costs and their important psychiatric components. Many drug treatment programmes are run by psychiatrists, and the evidence strongly supports the notion that a significant proportion of severe drug abusers are psychiatrically ill. Moreover, drug misuse appears to be becoming more frequent in patients with other psychiatric disorders, where it can lead to problems in treatment and poorer outcomes. It is therefore essential for all psychiatrists and related health professionals to have a good understanding of the basis of drug misuse.


1998 ◽  
Vol 28 (2) ◽  
pp. 381-394 ◽  
Author(s):  
David Farabee ◽  
Carl G. Leukefeld ◽  
Lon Hays

The Presidential Commission on the Human Immunodeficiency Virus Epidemic (1988) developed a 10-year plan in 1987 that recommended: “Expanded drug abuse treatment programs sufficient to admit all IV drug users who desired services and, until that occurred, short-term detoxification and low-dose methadone for those on waiting lists.” This study presents data collected from a sample of 2,613 out-of-treatment and non-incarcerated injection drug users in 21 U.S. cities to examine their drug-treatment access during the past year. Analyses on injectors who tried but were unable to enter treatment revealed that program-based reasons (e.g., no room, too costly, or stringent admission criteria) are the most commonly given barriers to drug treatment (72%). However, a notable number of injectors (20%) also reported that individual-based reasons are important for not accessing drug treatment. Injectors giving program- and individual-based reasons for not entering treatment are profiled using logistic regression.


PEDIATRICS ◽  
1990 ◽  
Vol 85 (2) ◽  
pp. 223-225
Author(s):  
WENDY CHAVKIN ◽  
STEPHEN R. KANDALL ◽  
STEPHEN R. KANDALL

In July 1989 in Sanford, Florida, in a trial at which one of us served as an expert witness for the defense, a woman was convicted of having administered cocaine to a minor—via the umbilical cord in the seconds between the infant's delivery and the clamping of the cord. Although she did not receive a jail sentence, the mother was sentenced to 15 years' probation, 200 hours of community service, mandatory drug treatment, and mandatory high school equivalency education. This prosecution is not an isolated example. The District Attorney of Butte County, California, announced his intention to prosecute all mothers of neonates with illegal drugs found in their urine; conviction would carry a mandatory minimum sentence of 90 days in jail.


1994 ◽  
Vol 24 (2) ◽  
pp. 331-348 ◽  
Author(s):  
Douglas S. Lipton

The incarceration of persons found guilty of various crimes who are also chronic substance abusers presents an important opportunity for treatment. It is an important opportunity because they would be unlikely to seek treatment on their own, without treatment they are very apt to continue their drug use and criminality after release, and cost effective drug abuse treatment methods are now available to treat them while in custody (both during incarceration and aftercare) and significantly alter their lifestyles. Correctional authorities should now feel optimistic that chronic heroin and cocaine users with predatory criminal histories can be treated effectively. This article shares the success of the Stay'n Out and Cornerstone Programs that have been successful with serious drug abusing offenders, and the factors that make for success. It is the proper program components joined by thoughtful leadership in the right setting. These principles are generalizable and transferable to many locations.


1993 ◽  
Vol 23 (1) ◽  
pp. 61-73 ◽  
Author(s):  
Thomas J. Hayes ◽  
Dennis J. Schimmel

The Bureau of Prisons (BOP) has undertaken a major initiative to provide residential drug abuse treatment to incarcerated offenders. The residential program represents the most comprehensive and intensive option in a three-tiered drug abuse treatment strategy adopted by the BOP and available to federal inmates. The purpose of this article is to provide an overview of the development, structure and content of this program. As such, a brief history of drug treatment for federal prisoners is offered, with specific emphasis on how earlier treatment programs influenced the current strategy. Implementation and organization are discussed to provide insight into both the treatment and unit-based structure of prison-based drug treatment. An introduction to the specific content areas covered during treatment is provided as a primer to the comprehensive concept endorsed in the development of the program. Finally, the importance of community transition and the steps taken by treatment and unit staff to facilitate transition is provided.


Sign in / Sign up

Export Citation Format

Share Document